Abstract
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders characterized by one or more peripheral blood cytopenias and trilineage dysplasia in the bone marrow. The approximate incidence is two to three cases for a population of 100,000 annually.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Bennett JM, Catovsky D, Daniel MT, et al. (for the French-American-British (FAB) Co-operative Group). Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–199.
Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994; 87: 746–754.
Beran M, Kantarjian H, O’Brien S, et al. Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood 1996; 88: 2473–2479.
De Witte T, Van Biezen A, Hermans J, et al. Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Blood 1997; 90: 3853–3857.
Gassmann W, Schmitz N, Löffler H, De Witte T. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes. Semin Hematol 1996; 33: 196–205.
Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088.
List AF, Brasfield F, Heaton R, et al. Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome. Blood 1997; 90: 3364–3369.
Molldrem JJ, Caples M, Mavroudis D, et al. Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol 1997; 99: 699–705.
Sanz GF, Sanz MA (Prognostic factors in myelodysplastic syndromes). Leuk. Res 1992; 16: 77–86.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Munker, R., Hiller, E., Paquette, R. (2000). Myelodysplastic Syndromes. In: Modern Hematology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-203-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-59259-203-6_11
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5873-3
Online ISBN: 978-1-59259-203-6
eBook Packages: Springer Book Archive